Home / AMERICAN NEWS / Craig Venter targets cancer with $70 mil

Craig Venter targets cancer with $70 mil

Craig Venter, genome pioneer, targets age-related diseases

Craig Venter announced Tuesday he has collected a total of $70 million from numerous investors in order to launch HLI (Human Longevity, Inc.).  The goal of the organization is to build the largest sequencing project focused on gathering information on the “complete” human genotype, phenotype and microbiome.  This data will then be utilized to design “cell-based treatments” that would extend and improve the quality of human life.

The new company will be chaired by Craig Venter who will also be the CEO. The vice chairmen will be Robert Hariri of Celgene and Peter Diamandis of the X Prize Foundation.  HLI has already purchased two HiSeq X Ten gene sequencing systems from Illumina Inc., a well-known manufacturer of DNA sequencing machines and have optioned to purchase three additional machines at a later date.

craig venter

Craig Venter

Venter told the press: “This will be one of the largest data studies in the history of science and medicine.”  He added that the company will not only collect whole genome data but will also gather genetic data on the many microbes living on and in human beings.  Venter and company believe they can create better probiotics, superior diagnostics and exceptional drugs to improve health and wellness through gaining a true understanding of microbiomes.

Additionally, HLI will gather information on metabolome–the many biochemicals, fats and metabolites in the human body—in order to learn about the various circulating chemicals that improve health and influence how drugs work.  Venter’s first target will be some of the most challenging age-connected diseases such as cancer, dementia, diabetes, obesity and even heart and liver diseases.

Venter stated: “Cancer is one of the most actionable areas right now with genomic-based therapies.  (It is) just the first of a multitude of diseases we will be sequencing this year.”  To that end, HLI has already formed a partnership with the Moores Cancer Center at the University of California, San Diego to take on cancer.  They hope to sequence the genomes of patients and run complete genome sequences on their tumors.

Other collaborators include the biochemical profiling company Metabolon Inc. of North Carolina and of course the nonprofit J. Craig Venter Institute.  Venter concluded: “We’re hoping to make numerous new discoveries in preventive medicine.  We think this will have a huge impact on changing the cost of medicine.”

 (Image courtesy of Wikipedia)       

About Will Phoenix

W. Scott Phoenix, B.A., B.S. was born in Hawaii, raised in Pennsylvania and resides in California. He has been a published writer since 1978. His work has appeared (under various names) in numerous places in print and online including Examiner.com. He is a single parent of three children and has also worked as an actor, singer and teacher. He has been employed by such publications as the Daily Collegian and the Los Angeles Times.

642-874 74-678 70-243 hp2-z33 070-642 c2090-610 642-997 98-365 adm-201 aws-sysops 070-488 tk0-201 og0-093 300-135 ex0-005 70-347 300-101 icgb 3002 4a0-m01 c_tadm51_731 c_tscm62_66 640-875 mb6-703 pmi-sp icbb 1z0-808 300-320 1z0-052 70-466 itilfnd iia-cia-part3 c4090-971 400-101 cwna-106 1z0-803 9l0-012 70-448 mb2-704 640-722 070-347 412-79 2v0-620 hp2-z34 jn0-360 hp2-z31 070-411 1z0-061 400-051 pr000041 hp0-s42 070-412 hp2-b115 1z0-434 642-999 70-465 cissp 1y0-301 c2180-401 hp2-z12 mb6-704 ns0-157 070-486 300-115 mb5-705 640-864 642-889 70-488 352-001 070-483 cbap 2v0-621d 640-554 pmp 350-018 700-701 hp5-b04d 1z0-060 300-208 101 640-916 n10-006 70-341 9l0-422 700-501 1z0-053 70-480 jn0-660 70-410 070-461 a00-211 iia-cia-part1 70-487 c4040-252 300-206 hp0-s41 hp0-d31 220-802 70-687 98-367 210-260 tb0-123 1y0-201 70-462 ccd-410 200-120 dev-401 1v0-601 010-111 og0-091 070-487 1z0-062 hp0-a116 100-101 sk0-003 70-980 cca-500 2v0-621 70-417 cism 220-801 cisa 646-365 640-692 lx0-103 070-246 70-483 70-486 ex300 102-400 210-060 640-911 642-737 400-201 70-331 1z0-051 hp2-h35 500-260 hp0-y51 mb2-708 e10-001 pmi-rmp 101-400 070-480 70-533 300-070 98-349 cas-002 hp0-j73 c4040-251 pegacsa71v1 n10-005 700-039 sy0-401 70-463 642-980 jn0-102 e20-690 070-410 350-080 mb2-707 700-260 70-467 070-465 e05-001 70-413 312-49v8 98-364 prince2-foundation 1z0-804 1z0-047 vmce_v8 70-414 mb2-701 1z0-067 200-310 70-346 ex200 300-209 mb6-702 810-401 70-685 ns0-101 70-534 700-280 642-998 642-437 70-412 c_tfin52_66 70-532 1z0-133 p2080-099 itil c4040-250 810-403 70-662 1y0-400 ax0-100 300-075 70-461 70-411